Brief: SAB Biotherapeutics Announces 1-For-10 Reverse Stock Split
Jan 2 (Reuters) - SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT
* SAB BIOTHERAPEUTICS INC: WILL EFFECT REVERSE STOCK SPLIT
OF ITS
OUTSTANDING SHARES OF COMMON STOCK, EFFECTIVE AS OF 12:01 A.M.
EASTERN TIME ON JAN 5
* SAB BIOTHERAPEUTICS: REVERSE STOCK SPLIT INTENDED TO BRING
CO
INTO COMPLIANCE WITH NASDAQ'S LISTING REQUIREMENT REGARDING
MINIMUM SHARE PRICE
Source text for Eikon: ID:nGNX1ypwRz
Further company coverage: SABS.O
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies